Cadence Pharmaceuticals, Inc. (CADX) Posts Q3 Loss of 34c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CADX Hot Sheet
Price: $13.98 --0%
Financial Fact:
Research and development: 2.05M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Research and development: 2.05M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q3 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- New Horizon Aircraft (HOVR) Misses Q1 EPS by 6c
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
